Status:
WITHDRAWN
Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Conditions:
Alopecia
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
RATIONALE: Bimatoprost ophthalmic solution may help increase eyebrow and eyelash growth in patients who have undergone chemotherapy. PURPOSE: This randomized clinical trial is studying how wells bima...
Detailed Description
OBJECTIVES: Primary * To assess the effectiveness of bimatoprost ophthalmic solution in expediting regrowth of eyebrows and eyelashes in patients who have undergone chemotherapy for breast cancer an...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Meets 1 of the following criteria:
- Diagnosis of breast cancer (group 1)
- Completed chemotherapy within the past month that has resulted in eyebrow alopecia or eyelash hypotrichosis
- Eyebrow score of 0-2 or eyelash score of 0-2 on the study's qualitative eyebrow or eyelash growth chart
- Has no known underlying disease (group 2)
- Desires thicker, fuller, or more numerous eyebrows
- Exclusion criteria
- pregnant
- does not Speak a language adequately covered by study translator services
- cognitive impairment
- history of trauma or burn to the eyebrow region, alopecia areata, or trichotillomania
- known diagnoses possibly underlying or contributing to the state of the eyebrows including, but not limited to, telogen effluvium or anagen effluvium (group 2)
- active ocular disease (group 1)
- thyroid hormone level abnormalities (group 2)
- More than 2 years since prior ocular surgery (group 1)
- prior topical medication for increasing eyebrow growth within 30 days od starting study treatment
- concomitant chemotherapy for the treatment of cancer (group 1)
- concomitant therapy for eyelash or eyebrow growth
Exclusion
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00999557
Start Date
January 1 2016
Last Update
July 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Los Angeles
Los Angeles, California, United States, 90095